ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy.
نویسندگان
چکیده
Systemic chemotherapy is indicated in progressive or bulky advanced pancreatic neuroendocrine tumors (NETs) and in grade 3 (G3) neuroendocrine neoplasms (NENs) as per ENETS Guidelines. Chemotherapy may be considered in NETs of other sites (lung, thymus, stomach, colon, rectum) under certain conditions (e.g., when Ki-67 is at a high level (upper G2 range), in rapidly progressive disease and/or after failure of other therapies, or if somatostatin receptor imaging is negative). An ENETS D ow nl oa de d by : K in gs 's C ol le ge L on do n 13 7. 73 .1 44 .1 38 4 /6 /2 01 7 4: 59 :1 8 P M
منابع مشابه
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.
aMedical Department, Endocrine Unit, Uppsala University Hospital, Uppsala, Sweden; bUniversity Sapienza Roma, Rome, and cMedical Oncology, Istituto Nazionale Tumori, Milan, Italy; dHepatogastroenterology and Digestive Oncology, Hôpital Ambroise, Boulogne, France; eDepartment of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Berlin, Germany; fIstitu...
متن کاملENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.
The landscape of treatment options in neuroendocrine tumors (NET) has changed in the last 5 years. Novel targeted drugs have been introduced and approved for distinct types of NET. Furthermore, with the first randomized trial on 177 LuDOTATATE peptide receptor radionuclide therapy (PRRT) in midgut NET, not only is approval of this treatment awaited but also its more widespread use. Techniques a...
متن کاملENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.
aDepartment of Internal Medicine, Endocrine Unit, Uppsala University Hospital, Uppsala, Sweden; bDepartments of Internal Medicine and Endocrinological and Metabolic Sciences, University of Genoa, Genoa, Italy; cG. Genimatas Hospital, Athens, Greece; dDepartment of Surgery, Rigshospitalet, Copenhagen, Denmark; eNetherlands Cancer Centre, Amsterdam, The Netherlands; fDepartment of Hepatology and ...
متن کاملENETS 2016 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update.
The participants at the conference were asked to focus on the relevant literature published between 2011 and 2015. They met over two and a half days, in which data and new evidence were presented. The participants then retreated to break-out sessions according to their disciplines and were required to answer questions listed in a workbook created by the session chairs and the organizing committ...
متن کاملENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.
The purpose of this guideline is to assist physicians caring for patients with neuroendocrine tumors in considering eligibility criteria for peptide receptor radionuclide therapy (PRRT), and in defining the minimum requirements for PRRT. This guideline also makes recommendations on what minimal patient, tumor, and treatment outcome characteristics should be reported for PRRT in order to make co...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Neuroendocrinology
دوره 105 3 شماره
صفحات -
تاریخ انتشار 2017